Stereotaxis, Inc. (STXS) earnings
STXS earnings moved a median of -0.27% by the close. Quarterly and annual STXS reports and results, each read against the price at its own news timestamp. Back to the STXS overview →
21 measured STXS earnings events.
Where these STXS earnings landedvs 21 measured STXS earnings reactions
| Middle 50% of STXS earnings reactions | -2.56% to +0.89% |
|---|---|
| Median reaction (to close) | -0.27% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 STXS earnings events with a measured close landed between -2.56% and +0.89%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Stereotaxis, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.07% | -1.43% | |
| Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026 | Press release | -4.30% | -2.65% | |
| Form 10-Q Stereotaxis, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.27% | |
| Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026 | Press release | +0.00% | -3.03% | |
| Form 10-K/A Stereotaxis, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.53% | -4.08% | |
| Form 10-K Stereotaxis, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.03% | +0.00% | |
| Form 10-Q Stereotaxis, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.42% | +1.89% | |
| Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025 | Press release | -0.32% | -1.93% | |
| Form 10-Q Stereotaxis, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.38% | +1.70% | |
| Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025 | Press release | +0.00% | +0.89% | |
| Form 10-Q Stereotaxis, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.21% | -3.77% | |
| Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025 | Press release | +0.00% | +6.99% | |
| Form 10-K Stereotaxis, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.72% | +5.98% | |
| Form 10-Q Stereotaxis, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.86% | |
| Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024 | Press release | +0.00% | +0.00% | |
| Form 10-Q Stereotaxis, Inc. For: Jun 30 | SEC filing · Form 10-Q | — | -0.34% | |
| Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024 | Press release | +0.30% | +3.52% | |
| Form 10-Q Stereotaxis, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.47% | -2.56% | |
| Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024 | Press release | +0.00% | +0.40% | |
| Form 10-K Stereotaxis, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.19% | +0.38% | |
| Form 10-Q Stereotaxis, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.69% | -0.69% |
Keep exploring
More STXS: analyst actions → · SEC filings → · STXS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (DE) (PLX) | 197 | 0.00% | 43% |
| AC Immune SA (ACIU) | 195 | -0.43% | 42% |
| Shineco, Inc. (TYHT) | 195 | -0.59% | 39% |
| INNOVATE Corp. (VATE) | 194 | +0.04% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.